255 related articles for article (PubMed ID: 15241854)
61. [Serological diagnosis in HIV infection].
NeguĊ£ EA; Usein CR
Bacteriol Virusol Parazitol Epidemiol; 1997; 42(3):125-30. PubMed ID: 9417280
[No Abstract] [Full Text] [Related]
62. FDA to consider home test kits for HIV.
Am Pharm; 1990 Aug; NS30(8):16-7. PubMed ID: 2396596
[No Abstract] [Full Text] [Related]
63. New rapid HIV test opens Pandora's box of ethical concerns.
Sibbald B
CMAJ; 2000 May; 162(11):1600. PubMed ID: 10862238
[No Abstract] [Full Text] [Related]
64. Research, clinic experience pave way for the HIV screening. Partnerships with state health departments.
AIDS Alert; 2010 Feb; 25(2):15-7. PubMed ID: 20458806
[No Abstract] [Full Text] [Related]
65. Value of early testing stressed during national AIDS event.
AIDS Policy Law; 2003 Jul; 18(13):5. PubMed ID: 12913968
[No Abstract] [Full Text] [Related]
66. [Biologic diagnosis of HIV infections].
Quaranta JF
Soins; 1992 Jan; (556):30-1. PubMed ID: 1609322
[No Abstract] [Full Text] [Related]
67. Company says it has new diagnostic test.
AIDS Alert; 2001 Aug; 16(8):108. PubMed ID: 11547702
[No Abstract] [Full Text] [Related]
68. Consumers warned about unapproved test kits.
AIDS Alert; 2005 Apr; 20(4):47-8. PubMed ID: 15841531
[No Abstract] [Full Text] [Related]
69. Negligence. Company might be liable for false-negative HIV test.
AIDS Policy Law; 2005 Feb; 20(4):7. PubMed ID: 15776517
[No Abstract] [Full Text] [Related]
70. Plans for HIV kits on hold after false-positive results.
Nurs Stand; 2006 Feb 1-7; 20(21):18. PubMed ID: 16482876
[No Abstract] [Full Text] [Related]
71. Point-of-care HIV testing using rapid HIV test kits: guidance for health-care professionals.
Can Commun Dis Rep; 2007 Nov; 33 Suppl 2():1-22. PubMed ID: 18074430
[No Abstract] [Full Text] [Related]
72. Home testing to detect human immunodeficiency virus: boon or bane?
Campbell S; Klein R
J Clin Microbiol; 2006 Oct; 44(10):3473-6. PubMed ID: 17021069
[No Abstract] [Full Text] [Related]
73. Home testing kit controversy.
Posit Aware; 1995; ():5. PubMed ID: 11362208
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of commercial HIV test kits used in Nigeria.
Banwat EB; Peter JY; Egah DZ
Niger J Clin Pract; 2009 Mar; 12(1):11-4. PubMed ID: 19562913
[TBL] [Abstract][Full Text] [Related]
75. Impact of expanded HIV screening.
Lander D
Ann Intern Med; 2007 Jul; 147(2):145-6; author reply 146-7. PubMed ID: 17638721
[No Abstract] [Full Text] [Related]
76. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
Wesolowski LG; MacKellar DA; Facente SN; Dowling T; Ethridge SF; Zhu JH; Sullivan PS;
AIDS; 2006 Aug; 20(12):1661-6. PubMed ID: 16868448
[TBL] [Abstract][Full Text] [Related]
77. CLIA waiver crucial to rapid test adoption. Study finds numerous errors for waived tests.
AIDS Alert; 2003 Mar; 18(3):33. PubMed ID: 12635604
[TBL] [Abstract][Full Text] [Related]
78. Access to HIV/AIDS drugs and diagnostics of acceptable quality. Pilot procurement, quality, and sourcing project.
IAPAC Mon; 2002 Jun; 8(6):162-5. PubMed ID: 12154787
[No Abstract] [Full Text] [Related]
79. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays.
Ly TD; Laperche S; Brennan C; Vallari A; Ebel A; Hunt J; Martin L; Daghfal D; Schochetman G; Devare S
J Virol Methods; 2004 Dec; 122(2):185-94. PubMed ID: 15542143
[TBL] [Abstract][Full Text] [Related]
80. Update: New Jersey AIDS testing, reporting and confidentiality requirements.
Tamborlane TA; Kunz DA
J N J Dent Assoc; 1997; 68(2):27-9. PubMed ID: 9540738
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
